Company Profiles

driven by the PitchBook Platform

Regentis Biomaterials

Regentis Biomaterials
2004 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$1.5M LATEST DEAL AMOUNT
12 INVESTORS
Description

Provider of tissue repair therapies designed to focus on repairing damaged tissue. The company's tissue repair therapies focus on orthopedic treatments using degradable hydrogel implants to regenerate damaged or diseased tissue, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Therapeutic Devices
Primary Office
12 Ha'ilan Street
Northern Industrial Zone, P.O.Box 260
Or-Akiva 3060000
Israel

+972 00-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Regentis Biomaterials’s full profile, request a free trial.

Regentis Biomaterials Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC $1.5M 000.00 Completed Generating Revenue
5. Later Stage VC (Series D) 05-Feb-2016 0000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 14-May-2012 0000 000.00 Completed Generating Revenue
3. Later Stage VC 01-Jan-2011 00.00 Completed Generating Revenue
2. Early Stage VC (Series B) 21-Aug-2007 $7.5M $8.1M Completed Startup
1. Early Stage VC 01-Nov-2004 $600K $600K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Regentis Biomaterials Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Generali Investments Europe Limited Partner Minority 000 0000 000000 0
Haisco Pharmaceutical Group Corporation Minority 000 0000 000000 0
Haisthera Scientific Fund Corporation Minority 000 0000 000000 0
Crossroad FCP Venture Capital Minority 000 0000 000000 0
Technion Research and Development Foundation Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Regentis Biomaterials Executive Team (7)

Name Title Board
Seat
Contact
Info
Alastair Clemow Ph.D Chief Executive Officer & President
Livnat Ben-Zur Israel Office General Manager & Executive Vice President, Business Development
Ron Arbel MD Chief Marketing Officer & Member Of Scientific Advisory Board
Dror Seliktar Ph.D Co-Founder & Chief Scientific Officer
Brooke Mastrorio Vice President, Clinical Affairs

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »

Regentis Biomaterials Board Members (8)

Name Representing Role Since Contact
Info
Ehud Geller Ph.D Medica Venture Partners Board Member 000 0000
Eli Hazum Ph.D Medica Venture Partners Board Member 000 0000
Ian Freelance DSM Venturing Board Member 000 0000
Jeff Dykan SCP Vitalife Partners Board Member 000 0000
Junmin Wang Haisco Pharmaceutical Group Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com